Purchase Order VA26213P0027

Cytopathology & Thyrosequence Testing Service Option Year 1 was awarded to Cytopath Biopsy Lab Inc. on October 1, 2022 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2. The firm fixed price delivery order, valued at $35,045, calls for cytopathology and thyrosequence testing services to be provided to the agency through September 30, 2023. Place of performance will be in Northport, New York. No set aside designation was applied to this...

This is a contract award to Cytopath Biopsy Lab Inc. (doing business as Cblpath) by the Defense Health Agency for ThyroSeq genetic testing services. Cytopath Biopsy Lab is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on cancer screening and diagnosis utilizing next-generation genomic sequencing. The $148,142.40 firm fixed price contract is for the provision of ThyroSeq testing, which involves analyzing genetic mutations to evaluate the...

The Defense Health Agency awarded a $105,000 firm fixed-price purchase order to Cytopath Biopsy Lab Inc. (doing business as Cblpath) on March 22, 2021, for ThyroSeq molecular diagnostic testing services. The contract, which is scheduled for completion by April 30, 2025, will be performed at Fort Belvoir, Virginia. No set-aside designation was used for this award. Cytopath Biopsy Lab Inc. specializes in anatomic pathology and molecular diagnostic laboratory services, with a primary focus on...

This is a firm fixed price purchase order awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of THROSEQ V.2 MOLECULAR TESTING services. The contract has a completion date of September 30, 2017 and a potential value of $150,000.00. Cblpath is a for-profit organization that provides specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and diagnosis utilizing next-generation...

This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $151,200.00. The contract is for the provision of ThyroSeq V.2 molecular testing services, which are used for cancer screening and diagnosis. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on delivering ThyroSeq testing to federal agencies, including the Department...

Cytopath Biopsy Lab Inc., doing business as Cblpath, was awarded a $201,600 firm fixed price call against the Defense Health Agency's Blanket Purchase Agreement to provide ThyroSeq next generation sequencing testing services. The single award contract has a period of performance through January 9, 2021 and was awarded on January 28, 2020 without a set-aside designation. Cblpath will deliver the thyroid sequencing tests from its laboratory located in Port Chester, New York to support the...

The Department of Veterans Affairs, Veterans Integrated Service Network 8, awarded a $288,000 firm fixed-price delivery order to Cytopath Biopsy Lab Inc. (doing business as Cblpath) on February 1, 2025, for ThyroSeq molecular diagnostic testing services. The contract, which has no set-aside designation, is scheduled for completion by January 31, 2026, with services to be performed in Port Chester, New York. ThyroSeq is a proprietary genetic testing service that analyzes mutations in thyroid...

This is a firm fixed-price purchase order awarded by the Defense Health Agency to Propath Services, LLC, a nationwide pathology practice that provides patient-centered medical diagnostics, prognostic assessments, and related services. The contract is for $125,000.00 and is for specialized laboratory studies and tests. This award is not a set-aside. Propath Services has previously provided services such as immunochemistry stains analysis, interpretation services, dermatopathology diagnostic...

This $64,400.00 firm fixed price delivery order was awarded to Cytopath Biopsy Lab Inc. (doing business as Cblpath) by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2. The order is for cytopathology and ThyroSequence genetic testing services to support the VA's cancer screening and diagnosis programs. Cblpath is a specialized anatomic pathology and molecular diagnostics laboratory that has previously provided ThyroSequence testing to the VA and Department of Defense...

This federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, is for the provision of TYROSEQ V.2 MOLECULAR TESTING services. The $150,000.00 firm fixed price purchase order was issued by the Defense Health Agency and does not have a set-aside designation. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on cancer screening and diagnosis utilizing next generation genomic sequencing under...